GenUs BioSystems

Executive Summary

GenUs BioSystems is a private diagnostics company based in Northbrook, Illinois, specializing in infectious disease testing with a focus on microarray technology. The company has demonstrated technical excellence through its participation in the FDA-led MicroArray Quality Control (MAQC) consortium, where it achieved the most reproducible and precise results among participants. This validation of its platform positions GenUs as a potential partner for large-scale diagnostic applications, though the company remains relatively small and unprofiled in terms of fundraising or commercial products. Its core strength lies in the reliability and accuracy of its microarray-based assays, which could be leveraged for syndromic infectious disease panels or antimicrobial resistance testing.

Upcoming Catalysts (preview)

• Q3 2026FDA clearance or CE marking for a new infectious disease panel40% success
• TBDPartnership or licensing deal with a larger diagnostics firm30% success
• Q3 2026Publication of clinical validation data for a novel assay60% success